|
Diseases | OS/MDF hallmarks | References |
|
Antiphospholipid Syndrome | Serum amyloid A, C-reactive protein, and 8-isoprostane and prostaglandin E2 | [249, 250] |
↑ peroxide production, nuclear abundance of Nrf2, antioxidant enzymatic activity; |
↓ intracellular GSH; altered ; beneficial effects of CoQ10 supplementation |
|
Pemphigus Vulgaris | ↑ MDA; ↓ antioxidants (Vit. A and E); ↓↑ CAT and ↓ GSH-Px; autoantibodies | [251–254] |
against desmosomal, mitochondrial, and other keratinocyte self-antigens |
|
Primary Biliary Cirrhosis | ↓ Antioxidant vitamins (A, C and E); ↓ GST, ↑ HOCl associated with eosinophil | [255–258] |
peroxidase; ↑ IgG against LOOH; serum and saliva antimitochondrial autoantibodies |
against E2 subunits of 2-oxoacid dehydrogenase enzymes (pyruvate dehydrogenase, |
2-oxo-acid dehydrogenase, and 2-oxo-glutarate dehydrogenase) |
|
Psoriasis | ↑ MDA, 8-OHdG, LOOH and NOx; ↓ CAT, SOD, GSH-Px, GSH and total | [259–263] |
antioxidant status; release of mitochondrial cytochrome c; ↑ CYP4F8 mRNA |
|
Rheumatoid Arthritis | ↑ LOOH; ↑ MPO, ↑ • and •OH in neutrophils from peripheral blood and | [264–269] |
synovial infiltrate; ↓ CAT, SOD, GSH-Px, GSH; TNF--associated ER stress; |
↑ AGE-IgG; chemokine (MCP-1/CCL2, RANTES/CCL5)-associated ROS; |
mtDNA mutations positively correlated with macroscopic synovitis |
|
Sjøgren’s Syndrome | ↑ protein carbonyl and AGEs; ↑ 4-HNE; ↑ TNF-, MPO and nitrotyrosine; | [270–274] |
↑ 8-OHdG and hexanoyl-lysine; ↑ Trx; ↑ LDH and mitochondrial GOT; |
antimitochondrial autoantibodies in patients’ saliva |
|
Systemic Lupus Erythematosus | ↓ CAT, SOD, GSH-Px, GSH; ↑ chemokine-associated ROS; | [264, 275, 276] |
↓ ATP; ↑ ; persistent mt hyperpolarization |
abnormal expression of mt pyruvate dehydrogenase complex |
|
Systemic Sclerosis | ↑ MDA, dityrosines and carbonyls; ↓ uric acid and total antioxidants status in | [277–280] |
saliva; ↓ GSH; ↓ SOD; ↑ GPx; plasma antimitochondrial autoantibodies |
|
Vitiligo | ↑ 4-HNE; ↓ cardiolipin; ↓ GSH; ↓ MPO; ↓ GST and CAT; ↑ GSTM1 null and | [281–283] |
GSTT1/GSTM1 double-null type; altered OXPHOS lipid-dependent subunits |
|